Opinion and Evidence in Respiratory Medicine
- PDF / 93,043 Bytes
- 4 Pages / 612 x 790.56 pts Page_size
- 113 Downloads / 174 Views
Am J Respir Med 2002; 1 (6): 447-450 1175-6365/02/0006-0447/$25.00/0 © Adis International Limited. All rights reserved.
Opinion and Evidence in Respiratory Medicine Contents Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1. Pediatric Asthma: Therapeutic Options Reviewed . . . . . . . . . 2. Albuterol: Beneficial Effects in Primary Pulmonary Hypertension . 3. Bacille Calmette-Géurin Vaccination Effective in Asthma . . . . . 4. Biofilms Aid Antibacterial Resistance in Cystic Fibrosis . . . . . . . 5. Liposomes Effective Allergen Carrier in Allergic Asthma . . . . . . 6. High-Dose Itraconazole Effective in Aspergillosis . . . . . . . . . . 7. Sildenafil Beneficial in Pulmonary Hypertension . . . . . . . . . . . 8. Green-Lipped Mussel Extract may Improve Symptoms of Asthma
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
. . . . . . . . .
447 447 448 448 448 449 449 449 450
Respiratory Medicine is a vast and evolving area for researchers, primary care physicians and specialists. To help keep you up-to-date with the latest advances worldwide on all aspects of drug therapy and management of respiratory disorders, this section of the journal brings you information selected from the drug therapy reporting service Inpharma Weekly1. The following reports are selected from the latest issues, summarizing the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse reaction news, and expert opinion pieces published across a broad range of literature sources.
1. Pediatric Asthma: Therapeutic Options Reviewed ‘The prevalence of pediatric asthma has risen sharply over the past 30 years, as has its impact on childhood morbidity and associated costs’, says Dr Robert Wood from Johns Hopkins University School of Medicine, Baltimore, US, in a recent editorial in JAMA. He comments that ‘these statistics are of particular concern because the understanding of asthma has clearly improved, as have the medications available for its control’. Reviewing the current therapeutic options available, Dr Woods notes that the recognition of asthma as a chronic inflammatory disease has led to greater emphasis being placed on the use of anti-inflammatory medication. Inhaled corticosteroids have become the principal treatment for persistent asthma, replacing agents such as theophylline and short-acting β-agonists, he says. Dr Woods goes on to say that recent advances have now made it possible to d
Data Loading...
